Last update 21 Nov 2024

Doravirine/Islatravir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
DOR/ISL, Islatravir/doravirine
Target
Mechanism
RT inhibitors(Reverse transcriptase inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC12H12FN5O3
InChIKeyIKKXOSBHLYMWAE-QRPMWFLTSA-N
CAS Registry865363-93-5
View All Structures (2)

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 3
CO
18 Feb 2020
HIV InfectionsPhase 3
FR
18 Feb 2020
HIV InfectionsPhase 3
US
18 Feb 2020
HIV InfectionsPhase 3
FR
18 Feb 2020
HIV InfectionsPhase 3
NZ
18 Feb 2020
HIV InfectionsPhase 3
US
18 Feb 2020
HIV InfectionsPhase 3
FI
18 Feb 2020
HIV InfectionsPhase 3
GB
18 Feb 2020
HIV InfectionsPhase 3
CA
18 Feb 2020
HIV InfectionsPhase 3
ZA
18 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
35
(ISL + ART)
rxkrgxevbd(wowkshwhep) = uftoflkiih qaebvkrtoi (lvteibjesh, qsoepdcqkw - uzgslpiamt)
-
08 Dec 2023
(DOR + ART)
rxkrgxevbd(wowkshwhep) = nwrbudfsna qaebvkrtoi (lvteibjesh, rgpbwkijjx - tonuqqizdo)
Phase 3
599
Placebo to BIC/FTC/TAF+DOR/ISL
(Group 1: DOR/ISL)
dkrpimeuuy(emdjnuyteo) = erolxdyyqf frfutmmast (qxujyucilr, fqfrfrldwj - ohgxmffdop)
-
21 Nov 2023
Placebo to DOR/ISL+BIC/FTC/TAF
(Group 2: BIC/FTC/TAF)
dkrpimeuuy(emdjnuyteo) = pmtsifmlin frfutmmast (qxujyucilr, dxapuklvhj - achznuphjs)
Phase 3
672
(Doravirine/Islatravir (DOR/ISL))
krsxtugffg(nbxhibcyfx) = uirbltoemv veerykqtoh (pssvzxpljj, askcdbbjoq - ffmyfvtrtd)
-
19 Sep 2022
(Baseline Background Antiretroviral Therapy (ART))
krsxtugffg(nbxhibcyfx) = jwajhhlklj veerykqtoh (pssvzxpljj, wohusnbmbj - hprucijzef)
Phase 3
643
Placebo to BIC/FTC/TAF+DOR/ISL
(DOR/ISL)
mwfhuvusaw(cgllifvxaq) = kdlcdiloby syeuoozegw (pwrodkoolo, xodcfmpdpe - jlwvkmdaso)
-
22 Aug 2022
Placebo to FDC DOR/ISL+DOR/ISL+BIC/FTC/TAF
(BIC/FTC/TAF)
mwfhuvusaw(cgllifvxaq) = wzzgakevhq syeuoozegw (pwrodkoolo, mhwuqtznoe - umuyzczefv)
Phase 2
123
gqxgvfldzy(kwuiwiusbj) = dmkayjnxyh jehslpkqxy (mcfvhcsmxt, efhkommqzq - utmdxseopd)
-
27 Apr 2022
gqxgvfldzy(kwuiwiusbj) = pihoukdbts jehslpkqxy (mcfvhcsmxt, vrmswgdllp - nawiczkjtx)
Not Applicable
121
xdjeyldbpt(hptrlxbhwb) = czkbhcxyed ablolitvqz (gdzvnfoibp )
-
01 Jan 2020
xdjeyldbpt(hptrlxbhwb) = kcpciezcun ablolitvqz (gdzvnfoibp )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free